Starting New FDA Approved Hepatitis C Therapies: What Patients Need to Know

This week, we will be starting therapy using the new FDA approved protease inhibitors, Victrelis (boceprevir) and Incivek (telaprevir) in our patients with chronic hepatitis C.

Below is a brief podcast explaining some of the procedures required prior to initiating therapy with these new agents.

Listen to the podcast here: Hepatitis C Treatment Introduction

Call our office at 713-794-0700 if you have questions.

Liver Specialists of Texas
6624 Fannin, Suite 1990
Houston, TX 77030

Tags: , , ,

2 Responses to “Starting New FDA Approved Hepatitis C Therapies: What Patients Need to Know”

  1. Gary Allen 10/01/2011 at 6:13 am #

    Dr. Galati you have all my labs Iwas wondering i would be a candidate for treatment Thanks Gary Allen

Leave a Reply